share_log

金斯瑞生物科技：截至二零二四年三月三十一日止月份之股份發行人的證券變動月報表

GENSCRIPT BIO: Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 March 2024

香港交易所 ·  Apr 2 19:54
Summary by Futu AI
金斯瑞生物科技於2024年4月2日向香港交易及結算所有限公司提交了最新的證券變動月報表，報告截至2024年3月31日的公司股份變動情況。報告顯示，公司的法定/註冊股本維持在5,000萬美元，每股面值0.001美元，本月未有增減。在已發行股份方面，首次公開發售後購股權計劃下，因行使期權而減少176,000股，並有260,098股期權失效，本月內因行使期權所得資金總額為1,353,940港元。此外，公司於3月25日根據股份獎勵計劃發行了447,870新股份。總計本月普通股增加了623,870股。
金斯瑞生物科技於2024年4月2日向香港交易及結算所有限公司提交了最新的證券變動月報表，報告截至2024年3月31日的公司股份變動情況。報告顯示，公司的法定/註冊股本維持在5,000萬美元，每股面值0.001美元，本月未有增減。在已發行股份方面，首次公開發售後購股權計劃下，因行使期權而減少176,000股，並有260,098股期權失效，本月內因行使期權所得資金總額為1,353,940港元。此外，公司於3月25日根據股份獎勵計劃發行了447,870新股份。總計本月普通股增加了623,870股。
Kingsway Biotechnology filed with Hong Kong Trading and Clearing Limited on April 2, 2024 its latest Securities Changes Monthly Report, reporting the changes in the company's shares as of March 31, 2024. The report showed that the company's regulated/registered share capital remained at $5,000 million with a face value of $0.001 per share, with no increase this month. In terms of issued shares, 176,000 shares were reduced as a result of the exercise of options and 260,098 share options expired under the initial public offering post-IPO share option scheme. The total amount of capital gained from the exercise of the option was HK$1,353,940 during the month. In addition, the company issued 447,870 new shares under the Share Award Scheme on March 25. In total, ordinary shares increased by 623,870 shares this month.
Kingsway Biotechnology filed with Hong Kong Trading and Clearing Limited on April 2, 2024 its latest Securities Changes Monthly Report, reporting the changes in the company's shares as of March 31, 2024. The report showed that the company's regulated/registered share capital remained at $5,000 million with a face value of $0.001 per share, with no increase this month. In terms of issued shares, 176,000 shares were reduced as a result of the exercise of options and 260,098 share options expired under the initial public offering post-IPO share option scheme. The total amount of capital gained from the exercise of the option was HK$1,353,940 during the month. In addition, the company issued 447,870 new shares under the Share Award Scheme on March 25. In total, ordinary shares increased by 623,870 shares this month.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1     View Translation

The translation is provided by third-party software.


The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content. It is only available to users located outside of China mainland.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.